Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Esketamine (intranasal)
Established treatments (listed in αbetical order)
Estimated phenotype frequency by ancestry for CYP1A2, CYP2D6, CYP2C19, CYP2C9 and CYP3A4.
Example protocols for transition from low-dose methadone to buprenorphine
Excited delirium
Excretory capacity of the kidney, estimation in renal impairment assessment
extended release (ER) preparations intramuscular injections memantine for older adults
extrapyramidal side effects (EPSEs) amisulpride features of most common symptoms high-dose antipsychotics patient sensitivity people with learning difficulties switching antipsychotics children first generation antipsychotics methamphetamine use plus antipsychotics people living with human immunodeficiency virus smoking alleviating symptoms treatment
Erectile dysfunction
Esketamine, enantiomer of ketamine
Espranor ododispersible buprenorphine brand
estimated glomerular filtration rate (eGFR), renal impairment assessment
Evidence and experience regarding the pharmacological treatment of motor symptoms in Huntington's disease (HD)
Examples of common unlicensed uses of drugs in psychiatric practice
Excretion of drugs, changes with old age
Expectations of treatment, placebo and nocebo effects